Table 1.
Total N=784 | N (%) |
---|---|
| |
Female | 447 (57) |
| |
Age-Mean ± SD (years) | 66 ± 11 |
| |
Race | |
American Indian or Alaskan Native | 3 (<1) |
Asian | 12 (2) |
Black or African American | 507 (65) |
White | 212 (27) |
Multiple Reported Races | 8 (1) |
Don’t Know/Refused | 42 (5) |
Ethnicity | |
Hispanic or Latino | 46 (6) |
Not Hispanic or Latino | 711 (91) |
Don’t Know/Refused | 27 (3) |
| |
Admission Comorbidities | |
Myocardial Infarction | 59 (8) |
Congestive Heart Failure | 251 (32) |
Peripheral Vascular Disease | 71 (9) |
Cerebrovascular Disease | 25 (3) |
Dementia | 0 (0) |
Chronic Pulmonary Disease | 211 (27) |
Rheumatic Disease | 40 (5) |
Peptic Ulcer Disease | 47 (6) |
Liver Disease | 126 (16) |
Diabetes | 344 (43) |
Hemiplegia/Paraplegia | 10 (1) |
Renal Disease | 165 (21) |
Cancer | 134 (17) |
AIDS/HIV | 10 (1) |
Sickle Cell Anemia | 21 (3) |
Gastrointestinal Bleeding | 98 (13) |
Depressive disorder | 103 (13) |
| |
Hemoglobin (Hb) Measures ± SD (g/dL) | |
Mean Hb | 8.5 ± 0.8 |
Median Hb | 8.4 ± 0.8 |
Minimum Hb | 7.3 ± 1.1 |
Maximum Hb | 9.8 ± 1.5 |
Admission Hb | 8.9 ± 1.8 |
Discharge Hb | 8.5 ± 0.9 |
| |
Transfusion During Hospitalization | 289 (35) |
| |
FACIT Fatigue Subscale Score (Range 0–52) | |
Mean ± SD | 26 ± 14 |
Median (IQR1–IQR3) | 27 (15–37) |
SD=Standard Deviation
Hb=Hemoglobin
FACIT=Functional Assessment of Chronic Illness Therapy
IQR=Interquartile Range